Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report

Abstract

Since fulminant Wilsonian liver failure has an extremely poor prognosis, the use of a liver support system that can bridge patients to liver transplant is life saving. We report here the case of a 17-year-old female who presented with fulminant Wilsonian liver failure and intravascular hemolysis. With the subsequent development of encephalopathy and oliguria, single pass albumin dialysis (SPAD) was initiated for 5 days to augment copper removal. Continuous venovenous hemodialysis (CVVHD) was performed using the PRISMA machine, with a blood flow of 100 ml/min and a dialysate flow of 2 L/h for 8 h, then 1 L/h. A 5% albumin dialysate was made by exchanging 1 L of 25% albumin for 1 L of Hemosol BO in a 5-L bag. Single pass albumin dialysis resulted in reductions in serum copper (154 to 59 μg/dL), conjugated bilirubin (37 to 23 mg/dL), lactate dehydrogenase (1305 to 729 units/L), and creatinine (1.1 to 0.9 mg/dL) as well as reduced blood transfusion requirements. Cessation of SPAD was followed by three plasmapheresis treatments for further copper removal. We conclude that SPAD is potentially an effective treatment in fulminant Wilson disease with hemolysis but that it should be used in combination with chelation to optimize the removal of copper.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877

    Article  Google Scholar 

  2. 2.

    Ferenci P (2004) Review article: diagnosis and current therapy of Wilson’s disease. Aliment Pharmacol Ther 19:157–165

    CAS  Article  Google Scholar 

  3. 3.

    Roberts EA, Schilsky ML (2003) A practical guideline on Wilson disease. Hepatology 37:1475–1492

    Article  Google Scholar 

  4. 4.

    Mitzner S, Klammt S, Stange J, Schmidt R (2006) Albumin regeneration in liver support—comparison of different methods. Ther Apher Dial 10:108–117

    CAS  Article  Google Scholar 

  5. 5.

    Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG (2007) Bench-to-bedside review: Current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care 11:215–223

    Article  Google Scholar 

  6. 6.

    Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH (2002) The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomized controlled clinical trial, and clinical experience from 19 centers. Artif Organs 26:103–110

    Article  Google Scholar 

  7. 7.

    Kreymann B, Seige M, Schweigart U, Kopp K-F, Classen M (1999) Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 31:1080–1085

    CAS  Article  Google Scholar 

  8. 8.

    Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr J-M, Liebe S, Emmrich, J, Korten G, Schmidt R (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized controlled clinical trial. Liver Transpl 6:277–286

    CAS  Article  Google Scholar 

  9. 9.

    Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R (2002) Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther 16:32–38

    CAS  Article  Google Scholar 

  10. 10.

    Manz T, Ochs A, Bisse E, Strey C, Grotz W (2003) Liver support-a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 21:232–236

    Article  Google Scholar 

  11. 11.

    Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, Williams R, Jalan R (2002) Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl 8:962–967

    Article  Google Scholar 

  12. 12.

    Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P (2004) In vitro comparison of the molecular adsorbent recirculation system (MARS) and Single-pass Albumin Dialysis (SPAD). Hepatology 39:1408–1414

    CAS  Article  Google Scholar 

  13. 13.

    Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI (2004) Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis. Pediatrics 113:406–409

    Article  Google Scholar 

  14. 14.

    Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL (2005) Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 45:E51–E56

    Article  Google Scholar 

  15. 15.

    Peszynski P, Klammt S, Mitzner S, Stange J, Schmidt R (2002) Albumin dialysis: single pass vs. recirculation (MARS). Liver 22:40–42

    CAS  Article  Google Scholar 

  16. 16.

    Kiss JE, Berman D, Van Thiel D (1998) Effective removal of copper by plasma exchange in fulminant Wilson’s disease. Transfusion 38:327–331

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Elizabeth A. Harvey.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Collins, K.L., Roberts, E.A., Adeli, K. et al. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 23, 1013–1016 (2008). https://doi.org/10.1007/s00467-008-0761-x

Download citation

Keywords

  • Albumin dialysis
  • Artificial liver support
  • Continuous venovenous hemodialysis
  • Fulminant liver failure
  • Single pass albumin dialysis (SPAD)
  • Wilson disease